Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer

Lung Cancer

Volumn 59, Issue 1, 2008, Pages 24-31

  Suzuki, Hiromitsu ^a   Ouchida, Mamoru ^a   Yamamoto, Hiromasa ^a   Yano, Masaaki ^a   Toyooka, Shinichi ^a   Aoe, Motoi ^a   Shimizu, Nobuyoshi ^a   Date, Hiroshi ^a   Shimizu, Kenji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Chromosome 15; LOH; Lung cancer; SIN3A

Indexed keywords

GENE PRODUCT; HISTONE DEACETYLASE; MESSENGER RNA; TRANSCRIPTION FACTOR SIN3A;

ACETYLATION; ADULT; AGED; ALLELE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 15Q; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SIN3A GENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; REPRESSOR PROTEINS;

EID: 37549006745     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.08.002     Document Type: Article

References (40)

1. Wistuba I.I., Behrens C., Virmani A.K., Milchgrub S., Sved S., Lam S., et al. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res 59 (1999) 1973-1979
2. Sekido Y., Fong K.M., and Minna J.D. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1378 (1998) F21-F59
3. Shivapurkar N., Virmani A.K., Wistuba I.I., Milchqrub S., Mackay B., Minna J.D., and Gazdar A.F. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res 5 (1999) 17-23
4. Virmani A.K., Fong K.M., Kodagoda D., McIntire D., Hung J., Tonk V., et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 21 (1998) 308-319
5. Knudson Jr. A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68 (1971) 820-823
6. Wistuba I.I., Behrens C., Virmani A.K., Mele G., Milchgrub S., Girard L., et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60 (2000) 1949-1960
7. Girard L., Zochbauer-Muller S., Virmani A.K., Gazdar A.F., and Minna J.D. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60 (2000) 4894-4906
8. Dannenberg J.H., David G., Zhong S., van der T.J., Wong W.H., and Depinho RA. mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev 19 (2005) 1581-1595
9. Murphy M., Ahn J., Walker K.K., Hoffman W.H., Evans R.M., Levine A.J., and George D.L. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13 (1999) 2490-2501
10. Luo R.X., Postigo A.A., and Dean D.C. Rb interacts with histone deacetylase to repress transcription. Cell 92 (1998) 463-473
11. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391 (1998) 601-605
12. Lai A., Kennedy B.K., Barbie D.A., Bertos N.R., Yang X.J., Theberge M.C., et al. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol 21 (2001) 2918-2932
13. Brehm A., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., and Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391 (1998) 597-601
14. Kim H., Lee J.E., Cho E.J., Liu J.O., and Youn H.D. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res 63 (2003) 6135-6139
15. Melnick A., and Licht J.D. Histone deacetylases as therapeutic targets in hematologic malignancies. Curr Opin Hematol 9 (2002) 322-332
16. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J Clin 49 (1999) 33-64
17. Rampalli S., Pavithra L., Bhatt A., Kundu T.K., and Chattopadhyay S. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol Cell Biol 25 (2005) 8415-8429
18. Murphy M., Hinman A., and Levine A.J. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev 10 (1996) 2971-2980
19. Roperch J.P., Alvaro V., Prieur S., Tuynder M., Nemani M., Lethrosne F., et al. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat Med 4 (1998) 835-838
20. Doyon Y., Cayrou C., Ullah M., Landry A.J., Cote V., Selleck W., et al. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell. 21 (2006) 51-64
21. Nikolaev A.Y., Papanikolaou N.A., Li M., Qin J., and Gu W. Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex. Biochem Biophys Res Commun. 323 (2004) 1216-1222
22. Kondo E., Gu Z., Horii A., and Fukushige S. The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes. Mol Cell Biol 25 (2005) 4388-4396
23. Zhang Y., Akinmade D., and Hamburger A.W. The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription. Nucl Acids Res 33 (2005) 6024-6033
24. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., et al. Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Cell 124 (2006) 275-286
25. Ellenrieder V., Buck A., Harth A., Jungert K., Buchholz M., Adler G., et al. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells. Gastroenterology 27 (2004) 607-620
26. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., and Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
27. Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N., et al. ETO, a target of t(8, 21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol 21 (2001) 6470-6483
28. Ito T., Ouchida M., Ito S., Jitsumori Y., Morimoto Y., Ozaki T., et al. SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex. Lab Invest 84 (2004) 1484-1490
29. Gunduz M., Ouchida M., Fukushima K., Hanafusa H., Etani T., Nishioka S., et al. Genomic structure of the human ING1 gene and tumor- specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 60 (2000) 3143-3146
30. Ito T., Ouchida M., Morimoto Y., Yoshida A., Jitsumori Y., Ozaki T., et al. Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. Cancer Lett 224 (2005) 311-319
31. Bandaru V., Sunkara S., Wallace S.S., and Bond J.P. A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair 1 (2002) 517-529
32. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 (2002) 475-487
33. Phelan M.L., Sif S., Narlikar G.J., and Kingston R.E. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3 (1999) 247-253
34. Wang W., Cote J., Xue Y., Zhou S., Khavari P.A., Biggar S.R., et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15 (1996) 5370-5382
35. Trouche D., Le Chalony C., Muchardt C., Yaniv M., and Kouzarides T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci USA 94 (1997) 11268-11273
36. Wong A.K., Shanahan F., Chen Y., Lian L., Ha P., Hendricks K., et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60 (2000) 6171-6177
37. Reisman D.N., Sciarrotta J., Wang W., Funkhouser W.K., and Weissman B.E. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63 (2003) 560-566
38. Moinova H.R., Chen W.D., Shen L., Smiraglia D., Olechnowicz J., Ravi L., et al. HLTF gene silencing in human colon cancer. Proc Natl Acad Sci USA 99 (2002) 4562-4567
39. Yano M., Ouchida M., Shigematsu H., Tanaka N., Ichimura K., Kobayashi K., et al. Tumor-specific exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer. Int J Cancer 112 (2004) 8-13
40. Kemper J.K., Kim H., Miao J., Bhalla S., and Bae Y. Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP. Mol Cell Biol 24 (2004) 7707-7719